Who owns CELLECTAR BIOSCIENCES INC?
- Ticker: CLRB
- CUSIP Number: 15117f880
Tip: Access positions for across all investors
Analyze quarterly positions in Cellectar Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cellectar Biosciences stock
Who bought or sold CELLECTAR BIOSCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Caligan Partners | 470k | $1.3M | 100% | Jun 2026 |
|
| Stempoint Capital | 355k | $987k | 100% | Jun 2026 |
|
| Vanguard Capital Management | 327k | $910k | 300% | Jun 2026 |
|
| Silverarc Capital Management | 322k | $894k | 100% | Jun 2026 |
|
| Bleichroeder | 289k | $803k | 189% | Jun 2026 |
|
| Jupiter Topco | 274k | $759k | 100% | Jun 2026 |
|
| Balyasny Asset Management | 220k | $612k | 100% | Jun 2026 |
|
| Nantahala Capital Management | 220k | $612k | 100% | Jun 2026 |
|
| Empery Asset Management | 190k | $527k | 100% | Jun 2026 |
|
| Diadema Partners | 138k | $385k | 100% | Jun 2026 |
|
| Stonepine Capital Management | 105k | $291k | 100% | Jun 2026 |
|
| Persistent Asset Partners | 93k | $259k | 100% | Jun 2026 |
|
| Boothbay Fund Management | 85k | $237k | 100% | Jun 2026 |
|
| Geode Capital Management | 53k | $148k | 1% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 46k | $129k | 179% | Jun 2026 |
|
| Sequoia Financial Advisors | 22k | $61k | 16% | Jun 2026 |
|
| Acadian Asset Management | 17k | $46k | 100% | Jun 2026 |
|
| Northern Trust | 15k | $41k | 100% | Jun 2026 |
|
| Riverview Capital Advisers | 10k | $50k | 0% | Jun 2026 |
|
| BlackRock | 4.7k | $13k | 0% | Jun 2026 |
|
| UBS Group | 3.1k | $8.6k | -68% | Jun 2026 |
|
| Barclays | 561.00 | $1.6k | 100% | Jun 2026 |
|
| Morgan Stanley | 510.00 | $1.3k | 0% | Mar 2026 |
|
| TD Waterhouse Canada | 63.00 | $178.000200 | 0% | Jun 2026 |
|
| SBI Securities | 11.00 | $31.000200 | 0% | Jun 2026 |
|
| Advisor Group Holdings | 7.00 | $17.999800 | 600% | Jun 2026 |
|
| Jones Financial Companies, L.L | 3.00 | $8.000100 | 0% | Jun 2026 |
|
| Us Bancorp | 3.00 | $8.000100 | 0% | Jun 2026 |
|
| Danske Bank A/s | 2.00 | $6.000000 | 0% | Jun 2026 |
|
Who sold out of Cellectar Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Warberg Asset Management | Mar 2026 | 14k | $35k |
| Tower Research Capital | Mar 2026 | 793.00 | $2.0k |
| Vanguard Global Advisers | Mar 2026 | 563.00 | $1.4k |
| FMR | Mar 2026 | 10.00 | $25.000000 |